[1]
Simpson, E. , Yosipovitch, G. , Eyerich, K. , Staumont-Sallé, D. , Shahriari, M. , Gallo, G. , Wolf, E. , Pierce, E. , Liu, C. , Zhong, J. , Agell, H. and de Bruin-Weller, M. 2023. Lebrikizumab Provides Rapid Response in EASI Components and Itch in Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s279. DOI:https://doi.org/10.25251/skin.7.supp.279.